Introduction of a separate group for software in the regulatory nomenclature of medical devices in Russia

04

Sep 2020

The Ministry of Health has adjusted the nomenclature classification of medical devices, separating software, which is a medical device, into a separate group. The classification of software is given depending on the potential risk of its use. A potential risk class is assigned to software regardless of the potential risk class of the medical device in combination with which it is used. The order does not apply to medical products previously submitted for state registration.

The Federal Service for Surveillance in Healthcare informs that on August 10, 2020, the Ministry of Justice of the Russian Federation registered the order of the Ministry of Health of the Russian Federation dated 07.07.2020 No. 686n "On amendments to Appendices No. 1 and No. 2 to the order of the Ministry of Health of the Russian Federation dated June 6, 2012, No. 4n "On approval of the nomenclature classification of medical devices" (registration No. 59225).

This regulatory legal act provides the introduction of a separate section for the classification of software, which is a medical device, depending on the potential risk of its use, as well as a group in the nomenclature classification of medical devices by type.

Each software (medical device) can be attributed to only one class of potential risk of use:

  • Class 1 - low-risk software;
  • Class 2a - software with a medium degree of risk;
  • Class 2b - software with an increased degree of risk;
  • Class 3 - high-risk software.

The approach to the classification of software that is a medical device, depending on the potential risk of its use, presented in this order, is harmonized with the approaches described in the documents of the International Medical Device Regulatory Forum (IMDRF).

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more